Tumor-infiltrating Lymphocytes (tils) As an Independent Prognostic Factor for Early HER2+ Breast Cancer Patients Treated with Adjuvant Chemotherapy and Trastuzumab in the Randomized Shorther Trial
Annals of oncology(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要